4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid has been researched along with vadimezan in 1 studies
| Studies (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Trials (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Recent Studies (post-2010) (4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid) | Studies (vadimezan) | Trials (vadimezan) | Recent Studies (post-2010) (vadimezan) |
|---|---|---|---|---|---|
| 21 | 5 | 5 | 272 | 16 | 101 |
| Protein | Taxonomy | 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid (IC50) | vadimezan (IC50) |
|---|---|---|---|
| Stimulator of interferon genes protein | Mus musculus (house mouse) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begent, RH; Boden, R; Boxer, GM; Davies, L; Pedley, RB; Sharma, SK; Springer, CJ; Stribbling, SM | 1 |
1 other study(ies) available for 4-((2-chloroethyl)(2-mesyloxyethyl)amino)benzoylglutamic acid and vadimezan
| Article | Year |
|---|---|
Enhancement of antibody-directed enzyme prodrug therapy in colorectal xenografts by an antivascular agent.
Topics: Animals; Antineoplastic Agents; Carcinoembryonic Antigen; Colorectal Neoplasms; Female; gamma-Glutamyl Hydrolase; Glutamates; Humans; Immunoconjugates; Immunoglobulin Fab Fragments; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Nitrogen Mustard Compounds; Prodrugs; Transplantation, Heterologous; Xanthenes; Xanthones | 1999 |